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ABSTRACT
Several essential viral proteins are proposed to participate in genome encapsidation of human cytomegalovirus (HCMV), among
them pUL77 and pUL93, which remain largely uncharacterized. To gain insight into their properties, we generated an HCMV
mutant expressing a pUL77-monomeric enhanced green fluorescent protein (mGFP) fusion protein and a pUL93-specific anti-
body. Immunoblotting demonstrated that both proteins are incorporated into capsids and virions. Conversely to data suggest-
ing internal translation initiation sites within the UL93 open reading frame (ORF), we provide evidence that pUL93 synthesis
commences at the first start codon. In infected cells, pUL77-mGFP was found in nuclear replication compartments and dot-like
structures, colocalizing with capsid proteins. Immunogold labeling of nuclear capsids revealed that pUL77 is present on A, B,
and C capsids. Pulldown of pUL77-mGFP revealed copurification of pUL93, indicating interaction between these proteins, which
still occurred when capsid formation was prevented. Correct subnuclear distribution of pUL77-mGFP required pUL93 as well as
the major capsid protein (and thus probably the presence of capsids), but not the tegument protein pp150 or the encapsidation
protein pUL52, demonstrating that pUL77 nuclear targeting occurs independently of the formation of DNA-filled capsids. When
pUL77 or pUL93 was missing, generation of unit-length genomes was not observed, and only empty B capsids were produced.
Taken together, these results show that pUL77 and pUL93 are capsid constituents needed for HCMV genome encapsidation.
Therefore, the task of pUL77 seems to differ from that of its alphaherpesvirus orthologue pUL25, which exerts its function sub-
sequent to genome cleavage-packaging.
IMPORTANCE
The essential HCMV proteins pUL77 and pUL93 were suggested to be involved in viral genome cleavage-packaging but are
poorly characterized both biochemically and functionally. By producing a monoclonal antibody against pUL93 and generating
an HCMVmutant in which pUL77 is fused to a fluorescent protein, we show that pUL77 and pUL93 are capsid constituents, with
pUL77 being similarly abundant on all capsid types. Each protein is required for genome encapsidation, as the absence of either
pUL77 or pUL93 results in a genome packaging defect with the formation of empty capsids only. This distinguishes pUL77 from
its alphaherpesvirus orthologue pUL25, which is enriched on DNA-filled capsids and exerts its function after the viral DNA is
packaged. Our data for the first time describe an HCMVmutant with a fluorescent capsid and provide insight into the roles of
pUL77 and pUL93, thus contributing to a better understanding of the HCMV encapsidation network.
The life cycle of human cytomegalovirus (HCMV), the proto-type member of the betaherpesviruses, comprises a nuclear
phase that includes transcription of viral genes, replication of the
double-stranded DNA genome, assembly of procapsids, packag-
ing of the viral DNA into the preformed capsids, and maturation
of the DNA-filled capsids, promoting their egress into the cyto-
plasm, where they undergo secondary envelopment (1). Capsid
formation commences by assembly of the major capsid protein
(MCP; encoded by the UL86 open reading frame [ORF]) around
a protein scaffold formed by the assembly protein precursor
(UL80.5) and the protease precursor (UL80a), followed by stabi-
lization of theMCP capsomers through the triplex proteins, which
consist of two copies of the minor capsid protein (mCP; UL85)
and one copy of the mCP-binding protein (mCP-BP; UL46) (2,
3), resulting in spherical procapsids. The MCP assembles into
hexons and pentons, the latter being restricted to the vertices of
the eventually icosahedral capsid. The small capsid protein (SCP;
UL48.5) may be present already in procapsids (4), and in mature
capsids, it decorates the tips of the hexons but not of the pentons.
Procapsids are believed to constitute the substrate for viral ge-
nome packaging, duringwhich the scaffold is cleaved and expelled
from the capsids. Successful genome packaging generates DNA-
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filled C capsids. The two other nuclear capsid forms are empty
shells, with B capsids probably arising from spontaneous angular-
ization of procapsids and A capsids originating from abortive
packaging events without retention of the genomes within the
capsids (1, 3, 5, 6). B capsids were recently discussed to be inter-
mediate capsid forms during the genomepackaging process rather
than dead end products (7). While both A and B capsids lack
DNA, they are distinguished by the presence (B capsids) or ab-
sence (A capsids) of the scaffold protein.
The capsids of alpha-, beta- and gammaherpesviruses share
many characteristics, but differences also exist. Although HCMV
has the largest genome of all mammalian DNA viruses (240
kbp); the diameter of its capsid is similar to that of the herpes
simplex virus 1 capsid (HSV-1; genome size, 150 kbp). As a con-
sequence, encapsidated HCMV DNA is more densely packed (8),
resulting inDNA-filled capsids that are under higher pressure and
may thus need additional stabilization (9). Furthermore, the
structure of the HCMV inner tegument is distinct from that of
HSV-1, insofar as the HCMV tegument contacts both hexons and
pentons, whereas in HSV-1, the inner tegument is attached to
pentons only (10, 11). Moreover, HCMV encodes betaherpesvi-
rus-specific tegument proteins: e.g., pp150 (UL32) and pUL96.
Recently it was shown that pp150 is the most inner tegument
protein forming a netlike layer around the capsids (12). A fol-
low-up study disclosed the SCP as being necessary for recruitment
of pp150 to capsids (13), thus providing an explanation of why in
betaherpesviruses SCP is essential (14), while in HSV-1 it is dis-
pensable for viral growth. Taken together, these features of beta-
herpesviruses may point to divergent mechanisms in capsid mat-
uration and stabilization following genome packaging.
HCMV genome encapsidation requires at least five gene prod-
ucts, in addition to the proteins needed for procapsid assembly.
These are as follows: (i) the terminase subunits pUL56 andpUL89,
which bind to the concatemeric viral DNA and cleave it into unit-
length genomes (15–17); (ii) pUL51, which interacts with pUL56
and pUL89 and may represent a third subunit of the terminase
complex (18); (iii) the portal protein pUL104, present at one cap-
sid vertex (19, 20); and (iv) pUL52, whose function is elusive, yet
essential for genome cleavage-packaging (21). For only two of
those proteins, pUL51 and pUL52, are HCMV mutants available
that allow analysis of the phenotypic consequences caused by the
lack of either of these proteins (18, 21). This is in part due to the
difficulties in generating complementing systems for essential
HCMV proteins (22). Studies with alphaherpesvirus mutants, for
which complementing cells can be more easily established, re-
vealed that two additional viral proteins (pUL17 and pUL25) are
involved in encapsidation of genomes and their stable retention
within capsids. pUL17 and pUL25 form a heterodimer that is lo-
cated exclusively around pentons (23–26) and was therefore
named the “capsid vertex-specific component” (CVSC) (27).
Loading of the CVSC on DNA-filled capsids is assumed to label
mature capsids as ready for nuclear egress, which may be initiated
by interaction of the CVSC with the nuclear egress complex
(NEC).
Orthologous proteins to HSV-1 pUL25 exist throughout the
herpesviruses, and in HCMV, the orthologue is the UL77 protein.
However, the similarity of the amino acid sequences of pUL77 and
HSV-1 pUL25 is only moderate (37%). Based on the findings
obtained with alphaherpesviruses, pUL77 was proposed to repre-
sent an additional HCMV gene product involved in DNA encap-
sidation. So far, only one publication on pUL77 is available, re-
porting that it interacts with DNA and components of the HCMV
genome packaging machinery (28), but its role during HCMV
infection is unknown. HCMV does not encode a protein sharing
substantial sequence similarity with HSV pUL17; however, due to
a similar position within the viral genome, the HCMVUL93 ORF
was defined as a “positional homologue” of HSV-1 UL17. Until
now, the protein encoded by UL93 is completely uncharacterized.
The aim of this study was to investigate the HCMV proteins
pUL77 and pUL93 and their putative role during the infection
cycle. To this end, we generated an HCMV mutant expressing a
UL77-monomeric enhanced green fluorescent protein (EGFP)
fusion protein (UL77-mGFP) and produced a pUL93-specific
monoclonal antibody. The usage of an efficient transfection pro-
tocol for HCMV bacterial artificial chromosomes (BACs) (29)
made it possible to examine mutant HCMV genomes in which
eitherUL77 orUL93 is disrupted directly in BAC-transfected cells.
pUL77 and pUL93 were expressed as late proteins and were found
to be associated with nuclear capsids and virus particles. In cells
transfected withHCMVBACs lacking the UL77 or UL93ORF, we
did not detect unit-length genomes, and solely B capsids were
observed. Our data provide a characterization of pUL77 and
pUL93 in infected cells and assign a role to either protein in ge-
nome cleavage and packaging.
MATERIALS AND METHODS
Viruses and cells.The recombinant viruses and genomes generated in this
study are based on HCMV strain AD169 cloned as a bacterial artificial
chromosome (BAC) in Escherichia coli (30). pHB5 denotes the original
AD169 BAC, and pHG represents an enhanced green fluorescent protein
(EGFP)-expressing pHB5 derivative (31). hTERT-RPE-1 cells (Clontech)
were propagated as described previously (29). Cultivation of human fore-
skin fibroblasts (HFFs), preparation ofHCMVstocks, and analysis of viral
growth by standard plaque assay were done as reported before (30).
BACmutagenesis, transfection by adenofection, and analysis of vi-
ral DNA. Insertion of the monomeric EGFP (mGFP) sequence into ORF
UL77 of pHB5 was performed by en passantmutagenesis (32). ThemGFP
ORF togetherwith a kanamycin resistance cassette (Knr) and an I-SceI site
was amplified with primer pairs UL77-GFP2.for and UL77-GFP2.rev or
UL77-GFP3.for and UL77-GFP3.rev (Table 1) using plasmid pEP-
mGFP-in as the template (kindly provided by Beate Sodeik). The resulting
PCR products were recombined with pHB5 by red-, -, --mediated
homologous recombination in E. coli, resulting in pHB5-UL77-mGFP-2
and pHB5-UL77-mGFP-3. HCMVBACs carrying deletions inORFUL32
(pp150), UL93, or UL86 (MCP) were constructed in an analogous man-
ner with pHB5-UL77-mGFP-3 as the backbone, pEP-Kan-S2 as the tem-
plate, and the primer pairs given in Table 1. Deletion of the UL52 ORF
from pHB5-UL77-mGFP-3 was done as described previously (21), and
construction of pHG-UL77 lacking the UL77 ORF was reported else-
where (33). pHG-UL93 was generated by disrupting the UL93 ORF
utilizing the respective primers shown in Table 1. Successful mutagenesis
was verified for each BAC through restriction analysis and sequencing.
Isolation of BACs frombacterial cultures was done by applying an alkaline
lysis procedure as described before (34). To reconstitute virus progeny
fromHCMVBAC genomes, HFFs were transfected with defective adeno-
virus particles as carriers (“adenofection”) as published recently (29). For
investigation of recombinant HCMV genomes in which essential genes
were disrupted, hTERT-RPE-1 cells (3  106) were adenofected accord-
ingly with 3 g of BAC DNA prepared by a protocol yielding endotoxin-
free DNA (Nucleobond PC 500 EF kit; Macherey & Nagel, Düren, Ger-
many). To analyze viral DNA by pulsed-field gel electrophoresis (PFGE),
3  106 adenofected hTERT-RPE-1 cells were harvested on day 5 post-
transfection and cast into agarose blocks. The conditions of PFGE, South-
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ern blotting, and hybridization to the probe specific for the HCMV b-re-
peat region were as delineated earlier (21).
Protein biochemistry techniques and generation of a UL93-specific
MAb. To produce mouse monoclonal antibodies (MAb) directed against
pUL93, two different parts of UL93 were expressed as recombinant
proteins in E. coli. To this end, PCRproductswere generatedwith the prim-
ers UL93-N.for (5=-CGCGGATCCTTCTATGCCGTCTTCACTACG-3=)
and UL93-N.rev (5=-CGCAAGCTTGCGACTGCGCCAAAAGGAATT-
3=) orUL93-C.for (5=-CGCGGATCCGAGCTGAGCTACGATGACCAC-
3=) and UL93-C.rev (5=-CGCAAGCTTAAGATCGTCGAACGGCAAGC
G-3=) and pHB5 as the template and were cloned into plasmid pQE-30
(Qiagen, Hilden, Germany), giving rise to pQE-UL93-N and pQE-
UL93-C. Expression of the recombinant proteins pUL93-N and pUL93-C
and purification, immunization of mice, and generation of hybridoma
cultures was done as reported previously (18). Antibodies reactive with
the recombinant proteins were finally evaluated with HCMV-infected
cells by immunoblotting (IB) and immunofluorescence (IF) microscopy
done as described previously (18, 21, 29). Hybridoma cultures secreting
pUL93-specific antibodies were only obtained after immunization with
pUL93-N, but not with pUL93-C.Other antibodies usedwereGFPmouse
MAb (Santa Cruz; catalog no. sc-9996), UL44 and pp150 mouse MAb
(kindly provided by Bodo Plachter, University of Mainz, Germany), IE1
mouseMAb (NEA-9221; PerkinElmer), and anti-glyceraldehyde-3-phos-
phate dehydrogenase (anti-GAPDH) (rabbit MAb 14C10; Cell Signaling;
catalog no. 2118). The MCP-specific mouse MAb was obtained from
Klaus Radsak (University of Marburg, Germany), the pUL50 and pUL53
Abs were received fromManfredMarschall (University of Erlangen, Ger-
many), and theMAb directed against theHCMVSCPwas a kind gift from
William Britt (University of Alabama, Birmingham). Polyclonal rabbit
sera raised against the HCMVmCP or the mCP-BP were generously pro-
vided byWadeGibson (JohnsHopkins University, Baltimore,MD). Gen-
eration of MAbs specific for UL52, UL56, and UL89 was described previ-
ously (18). The kinetic class of HCMVprotein expressionwas determined
by applying inhibitors of early or late gene expression (cycloheximide/
actinomycin D or phosphonoacetic acid) as given elsewhere (21).
To pull down the UL77-mGFP fusion from infected HFFs, 4  106
cells were infected with either HB5 or HB5-UL77-mGFP-3 at a multiplic-
ity of infection (MOI) of 3, and on day 5 postinfection (p.i.) lysed in 1 ml
of immunoprecipitation (IP) buffer (50 mM Tris-HCl [pH 7.4], 300 mM
KCl, 5 mM EDTA, 0.5% NP-40, containing protease inhibitors [protease
inhibitor cocktail set II; Calbiochem]). After freezing at 	80°C, lysates
were thawed on ice, and insolublematerial was removed by centrifugation
for 15min at 4°C and 16,000 g. Each samplewas preclearedwith protein
G Sepharose before being incubated for 2 h at 4°C on a tumbling wheel
with 50 l of GFP-Trap_A beads (ChromoTek, Martinsried, Germany).
Beads were washed five times with IP buffer, and bound proteins were
eluted with 150 l of reducing buffer RotiLoad-1 (Carl Roth, Karlsruhe,
Germany). One percent of the cell lysates before IP and 8% of the eluted
material were separated by SDS-PAGE, transferred to nitrocellulose
membranes, and examined by IB with the Ab indicated. Pulldown of
pUL77-mGFP from adenofected hTERT-RPE-1 cells was performed in
the same way using 3 106 cells per sample.
Preparation of nuclear capsids and extracellular virions. For capsid
preparation, HFFs (1.6 107 cells) were infected at an MOI of 1. On day
5 p.i., cells were trypsinized, collected by centrifugation at 230  g for 7
min at 4°C, and washed once with MNT buffer (30 mM 2-[N-morpho-
lino]-ethanesulfonic acid, 100 mM NaCl, 20 mM Tris-HCl [pH 7.4]).
Cells were resuspended in 4 volumes of sterile water containing 10 mM
dithiothreitol (DTT) and protease inhibitors, incubated on ice for 1 min,
and snap-frozen in liquid nitrogen. After thawing at 37°C, cells were ho-
mogenized by passing 10 times through a hollow needle (0.6 30 mm),
and nuclei were pelleted (230 g, 7 min, 4°C) and resuspended in 4 pellet
volumes of TNE–1% Triton X-100–10 mM DTT. (TNE is 20 mM Tris
[pH 7.5], 0.5 M NaCl, and 1 mM EDTA.) Following snap-freezing in
liquid nitrogen and thawing at 37°C, nuclei were sonicated at 4°C (ampli-
tude of 60%with 10-s pulses until the sum of the applied energy was 4 kJ).
MgCl2 (final concentration, 1 mM) and 100 U of Benzonase were added,
and samples were incubated overnight on a tumbling wheel at 4°C. Ben-
zonase was inactivated by adding EDTA (pH 8.0) to a final concentration
of 20 mM, and debris was removed by centrifugation for 50 min at
8,000 g at 4°C. The supernatant was layered on 2 ml of 35% sucrose in
TNE–10 mMDTT, and capsids were pelleted at 70,000 g for 90 min at
4°C. Capsids were resuspended by adding 100 l of 20 mM Tris (pH
7.5)–150 mMNaCl–1 mM EDTA–10 mMDTT to the pellet, followed by
incubation on ice for 10 min and careful pipetting using a cut pipette tip.
Finally, capsids were snap-frozen in liquid nitrogen and stored at	80°C.
All steps were done at 4°C using ice-cold buffer solutions containing pro-
tease inhibitors. Gradient purification of capsids was done by following
previously described protocols with slight modifications (35, 36). HFFs
(5 107 cells) were infected as described above and harvested on day 4 p.i.
by trypsinization. After being washed in phosphate-buffered saline (PBS),
cells were resuspended in 20 mMTris-HCl (pH 7.5) and incubated on ice
for 20 min, followed by addition of Triton X-100 to a final concentration
of 1.5% and further incubation on ice for another 30 min. Nuclei were
spun down at 950  g for 10 min and resuspended in TNE, and subse-
quent sonication, Benzonase treatment, and removal of debris were per-
formed as delineated above. The resulting supernatant was layered on a 20
to 50% sucrose gradient (prepared in TNE) followed by centrifugation at
100,000 g for 60min at 4°C and collection of the light-scattering bands.
To purify virions from the supernatant of infected HFFs, mediumwas
harvested from cell cultures exhibiting 100% cytopathic effect (CPE), and
cell debris was removed by centrifugation at 3,500 g for 10 min at 4°C.
The samplewas layered on a 15% sucrose solution in virus standard buffer
(50 mM Tris-HCl [pH 7.8], 12 mM KCl, 5 mM EDTA) and centrifuged
for 90 min at 4°C at 70,000  g. The virus particles in the pellet were
resuspended in 150 l of Roti-Load 1.
EM. For analysis of intracellular capsids by transmission electron mi-
croscopy (EM), glass coverslips were seeded with adenofected hTERT-
RPE-1 cells and processed 5 days later essentially as described previously
(18). Cells were fixed for 1 h at room temperature with 2% (wt/vol) glu-
taraldehyde in 130 mM cacodylate buffer at pH 7.4 containing 2 mM
CaCl2 and 10 mMMgCl2. Then the cells were washed and postfixed with
1% (wt/vol)OsO4 in 165mMcacodylate buffer at pH 7.4 containing 1.5%
(wt/vol) K3[FeIII(CN)6] for 1 h, followed by incubation in 0.5% (wt/vol)
TABLE 1 Oligonucleotides used in this study to generate mutant HCMV BAC genomes
Primer name Sequence (5=¡3=)
UL77-GFP2.for CCCGCGGACGCTGCTACAACCACCGTGTCGTCCGCGTTCTGTGAGCAAGGGCGAGGAGCTGTT
UL77-GFP2.rev GGACGGCAGAAGCTCCTGCCACGCCGGTCCCTGGGGACGACTTGTACAGCTCGTCCATGCCGA
UL77-GFP3.for CGTGGTCGCCCCGTCTGACGCGGTCGCCGCGTCAGCGGCCGTGAGCAAGGGCGAGGAGCTGTT
UL77-GFP3.rev GCTCGGCGCACTGCGCCAGCCAGGTAGAAGAAGCACCGGCCTTGTACAGCTCGTCCATGCCGA
UL93-KO.for AAGTCGAACTATACCGGGCGTTGGACGCTTATCGGGCGTAGGACTGATTCGCGCCGTGCGCAAGGATGACGACGATAAG
UL93-KO.rev AGTACAGCGTAGATCTCGTCGCGCACGGCGCGAATCAGTCACTACGCCCGATAAGCGTCCAGCCAGTGTTACAACCAATT
UL32-ko.for CCGCGCTTACGAGCGCGCGTTCCACGATCTCGGCATCGTGCTAGTTACCTATTAACGGTCTAGCACCAAGGATGACGACGATAAG
UL32-ko.rev CGTGGTAAGGCGCGTGACCACCTGGCTGTGCTAGACCGTTAATAGGTAACTAGCACGATGCCGAGAGCCAGTGTTACAACCAATT
MCP-KO.for GCAGTGTCTGTAAAAAGCTGTGAATCAAGCCGCGCTCCATCTAGTTACCTATTACGCGCGCAGCACCCAAGGATGACGACGATAAG
MCP-KO.rev GATCCTCAACGTGGAAGCCATGCACACGGTGCTGCGCGCGTAATAGGTAACTAGATGGAGCGCGGCTGCCAGTGTTACAACCAATT
Borst et al.
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uranyl acetate in 50% (vol/vol) ethanol overnight. The cells were flat em-
bedded in Epon, and 50-nm sections were cut parallel to the substrate.
Images were taken with an FEI Morgagni electron microscope at a mag-
nification of 14,000, which allowed the identification of nuclear capsid
types. These images were stitched to larger images covering the entire
nuclear area using the “photomerge” function of the Adobe Photoshop
software. Nuclear A, B, and C capsids were counted, and the sectioned
nuclear areas weremeasured. For negative staining and immunogold EM,
preparations of nuclear capsids were adsorbed onto carbon and Formvar
film-coated 400 mesh copper grids (Stork Veco). As a negative control,
capsids of HB5-UL77-mGFP-3 were additionally treated with 2M guani-
dinium hydrochloride (GuHCl) for 1 h at room temperature (RT). The
samples were washed with PBS, followed either directly by negative stain-
ing or immunogold staining. For immunogold staining, grids were
blocked with 10 mg/ml bovine serum albumin (BSA) in PBS, incubated
for 30 min with rabbit GFP antiserum (Invitrogen) at a dilution of 1:100,
and washed with PBS, followed by a 15-min incubation with protein A-
labeled gold particles (10-nm diameter; Cell Microscopy Center, Utrecht
School of Medicine, The Netherlands). After being washed with PBS and
distilled water, preparations were negative stained using 2% (wt/vol) ura-
nyl acetate (Merck) and analyzed with a Tecnai G20 (FEI) at 200 kV.
Images of capsids were randomly taken at a magnification of 55,000.
Gold particles were counted.
RESULTS
Generation ofHCMVmutants expressing aUL77-mGFP fusion
protein. To investigate the UL77 protein in infected cells, we
aimed at generating an HCMVmutant that encodes pUL77 fused
to a fluorescent protein. Adding tags to essential viral proteins can
potentially impair their function. To minimize such effects, we
chose a monomeric EGFP (mGFP) that does not induce dimer
formation (37). Fromprevious experiments, we knew that tagging
of pUL77 at the N terminus is not compatible with virus growth,
but small epitope tags were successfully added to the C terminus
(33). Unexpectedly, insertion of the mGFP sequence after the last
codon of the UL77 open reading frame (ORF) was not compatible
with the production of viral progeny (data not shown). Instead,
we inserted mGFP after amino acid (aa) 114 or 154 of pUL77
because the respective domains are nonconserved compared to
the orthologous proteins of other herpesviruses (38) and presum-
ably form loops on the protein surface as suggested by structure
prediction of pUL77 (www.robetta.org [39]; data not shown). Re-
striction analysis of the resulting HCMV bacterial artificial chro-
mosomes (BACs) HB5-UL77-mGFP-2 and HB5-UL77-mGFP-3
displayed the expected shift of a 7.5-kbp BglII fragment (contain-
ing the UL77 ORF) to 8.3 kbp (Fig. 1A) due to insertion of the
mGFPORF. Following transfection of fibroblasts, both BACs gave
rise to infectious virus, and the virus mutants exhibited growth ki-
netics similar to that of the parentalHB5 virus (Fig. 1B). The integra-
tionof themGFPORFbetweencodons114and115of theUL77ORF
in the HB5-UL77-mGFP-2 BAC disrupts the partially overlapping
UL76 ORF. Although nonessential for replication of HCMV in cell
culture (as shown in reference 40 anddemonstrated here) or perhaps
even inhibitory (41), several functions have been assigned to UL76
(42, 43), including regulation of UL77 expression (44). Thus, we de-
cided to perform the further experiments with the mutant HB5-
UL77-mGFP-3, in which UL76 remains intact.
Characterization of the UL77-mGFP andUL93 proteins.We
first analyzed the expression of the UL77-mGFP fusion protein in
fibroblasts from day 1 to day 5 following infection with HB5-
UL77-mGFP-3 by immunoblotting with a GFP antibody (Fig.
1C). A protein of 100 kDa was detected that was expressed
mainly at late times of infection (day 3 to day 5), which is consis-
tent with the calculatedmolecularmass of theUL77-mGFP fusion
protein. To characterize the protein(s) encoded by ORFUL93, we
generated specific mouse monoclonal antibodies (MAbs) by im-
munizing mice with a bacterially produced recombinant protein,
comprising aa 125 to 339 of the predicted UL93 protein (gray box
of the UL93 scheme in Fig. 1D).When tested by immunoblotting,
two of the obtained MAbs reacted well with lysates of HCMV-
infected cells but performed poorly in immunofluorescence (IF)
experiments (not shown). Both MAbs detected a viral protein of
70 kDa and also reacted with a weaker band migrating at 48
kDa (e.g., see Fig. 1C, lane 6). When testing the lysates of HB5-
UL77-mGFP-3-infected cells harvested on day 1 to day 5 by im-
munoblotting with one of the pUL93-specific MAbs, the 70-kDa
protein was the prominent form, which considerably increased in
amount during the viral infection cycle, whereas the 48-kDa pro-
tein (Fig. 1C, asterisk) was present in small amounts only and did
not change much over time. The70-kDa band probably repre-
sents the expected 68-kDa protein encoded by the full-length
UL93 ORF as first annotated by Chee et al. (45). This is an inter-
esting finding because a recent study did not find evidence for
usage of the most 5=-located start codon of the UL93 ORF when
applying ribosome profiling analysis of mRNAs extracted from
HCMV-infected cells (46). Their data rather suggested that trans-
lation of the UL93 transcript starts at downstream initiation
codons, giving rise to a protein of 422 aa (ORFL221W, 48 kDa)
and two smaller ones. The observed 48-kDa band would be in line
with alternative initiation of protein synthesis (possibly at codon
173 of theUL93ORF, as proposed [c.f., UL93 scheme in Fig. 1D]);
however, the main initiation site appears to be the first ATG.
To determine whether pUL77 and pUL93 are immediate early
(IE), early (E), or late (L) proteins, infected cells were either left
untreated or were incubated with inhibitors typically used to ar-
rest HCMV gene expression in the respective phase of the infec-
tion cycle. IE1, UL44, and UL52 served as controls for immediate
early, early, and late viral proteins, respectively. As can be seen in
Fig. 1D, both pUL77-mGFP and pUL93 were expressed efficiently
only in the absence of inhibitors (lane 4, L), classifying them as late
proteins.
Next we analyzed the subcellular localization of the UL77-
mGFP fusion protein during the course of HCMV infection by
confocal laser scanning microscopy. In nuclei of infected cells (la-
beled by IE1), pUL77-mGFP became detectable on day 3 p.i. in
patches reminiscent of replication compartments (Fig. 2A). Addi-
tionally, green fluorescent dots were visible outside the replication
compartments later (Fig. 2A, d4 and d5) and finally throughout
the whole nucleus (Fig. 2A, d6). To check whether these dots also
contain capsid proteins, cells infected with HB5-UL77-mGFP-3
were labeled on day 5 p.i. with antibodies specific for the major or
small capsid protein (Fig. 2B). The green fluorescent dots over-
lapped almost completely with the signals for the capsid proteins,
especially with the ones for the major capsid protein (MCP) (Fig.
2B, upper panel). The larger dots with sizes of 800 to 1,000 nm
may result from accumulation of several capsids, whereas the
smaller dots (400 nm) may constitute individual fluorescent
capsids. Taken together, these results suggest that pUL77-mGFP
associates with capsid proteins, possibly with complete capsid
shells.
pUL77-mGFP andpUL93 are present on nuclear capsids and
in extracellular virions. To gain further insight into the capsid
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association of pUL77-mGFP and pUL93, we isolated capsids from
the nuclei of infected cells. At first, capsids were pelleted by ultra-
centrifugation, which allowed us to isolate intact capsids of all
three types (A, B, and C capsids) from nuclei of fibroblasts in-
fected with either the parental HB5 virus or HB5-UL77-mGFP-3
(Fig. 3A). Analysis of these capsid preparations by immunoblot-
ting showed the presence of pUL77-mGFP in capsids derived
from cells infected with the mutant (Fig. 3B, top panel, lane 3).
pUL93 was present as well in nuclear capsids, with only the 68-
kDa full-length formbeing detected (Fig. 3B, second panel, lanes 3
and 4). Other known capsid proteins (MCP, mCP, mCP-BP, and
SCP) were readily identified as expected, and also the betaherpes-
virus-specific tegument protein pp150 was found to be associated
with capsids. This is in line with data reporting that attachment of
pp150 to capsids starts already in the cell nucleus, presumably
stabilizing C capsids during nuclear egress (12, 13, 47, 48). How-
ever, we cannot exclude that a portion of pp150 detected here
originates from some cytoplasmic capsids copurifying with the
nuclear capsids and not solely from C capsids. To evaluate the
quality of the capsid preparations, several viral nuclear as well as
cellular proteins served as controls. pUL52, anHCMV late protein
required for genome cleavage and packaging, the viral polymerase
processivity factor pUL44, and the viral regulatory protein IE1
were detected in minimal amounts only, and actin and GAPDH
were absent (Fig. 3B, bottompanels). This confirmed the purity of
the capsids. Moreover, the viral nuclear egress proteins pUL50
and pUL53 were present in marginal amounts only, similar to the
background signals obtained for nonstructural viral control pro-
teins (Fig. 3B, panels 7 and 8).
Next we asked to which types of capsids pUL77-mGFP is at-
tached by performing immunogold labeling with a GFP antibody
followed by electron microscopy (EM). As can be seen in Fig. 3C,
there was specific labeling of HB5-UL77-mGFP A, B, and C cap-
sids compared to the background signal obtained forHB5 capsids,
yet we did not observe preferential labeling of A or C capsids as
described for alphaherpesviruses. Upon treatment of HB5-UL77-
mGFP capsids with guanidinium hydrochloride (GuHCl), the oc-
cupancy of capsids with gold particles was reduced to background
level, thus corroborating the localization of pUL77-mGFP on the
capsid surface.
A B
d2
d3
d4
d5
d6
UL77-mGFP
UL77-mGFP
UL77-mGFP
IE1 merge
merge
merge
MCP
SCP To-Pro-3
To-Pro-3
FIG 2 Subcellular localization of pUL77-mGFP in infected cells. (A) Fibroblasts were infected with HB5-UL77-mGFP-3 (MOI, 0.1) and fixed on days 2 to 6 p.i.
The UL77-mGFP fusion protein was detected by fluorescencemicroscopy, and labeling of the viral IE1 protein with a specific Ab was used to delineate the nuclei
of infected cells. (B) Fibroblasts infected with HB5-UL77-mGFP-3 at anMOI of 0.1 were fixed on day 5 p.i. The UL77-mGFP fusion protein was detected via the
GFP fluorescence, To-Pro-3 was used to stain nucleic acid, and capsid proteins were visualized with Abs directed against the major capsid protein (MCP; upper
panel) or the small capsid protein (SCP; lower panel). Scale bars, 5 m.
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Since the comparable amounts of pUL77-mGFP on all three
capsid types contrast with the findings obtained for alphaherpes-
viruses, we further investigated this aspect by using gradient-pu-
rified capsids. Albeit well established with alphaherpesviruses, the
procedure is challenging for HCMV because of the much lower
number of nuclear capsids produced and their reduced stability
(35, 36). Upon rate velocity sedimentation of nuclear capsids in a
sucrose gradient, the light-scattering bands were collected and
analyzed by negative staining and EM. The upper two bands ex-
hibited efficient enrichment of either A or B capsids—namely,
85% A capsids and 80% B capsids, respectively. The band below
was very faint—an observation also made by others (36)—and
contained only 5% C capsids besides numerous A and B capsids,
and also many damaged capsids (data not shown). This is proba-
bly due to the larger and more densely packed HCMV genome
compared to those of other herpesviruses, resulting in a high in-
ternal capsid pressure more easily leading to capsid rupture. The
purified A and B capsids were examined by immunoblotting for the
presenceofpUL77-mGFPafternormalizationof the samples toequal
amountsofMCP(Fig. 3D).Comparable levelsofpUL77-mGFPwere
detected on both capsid types, and the same was found for pUL93.
We could not check the latter finding by immunogold labeling and
EM until now because the UL93-specific antibody does not work
when the native protein has to be recognized. These results provide
further evidence that pUL77-mGFP is not preferentially associated
with one type of capsids, as is the case with the alphaherpesvirus
orthologue pUL25, andmoreover indicate that also pUL93 is present
in A and B capsids in similar amounts.
Some viral proteins interact only transiently with capsids and
dissociate after accomplishing their task (e.g., the terminase sub-
units or the proteins of the nuclear egress complex), whereas oth-
ers are retained as structural components. Therefore, we tested
whether pUL77-mGFP and pUL93 are present in extracellular vi-
rions. Virus particles were purified from the supernatant of fibro-
blasts infected with either the parental virus HB5 or the HB5-
UL77-mGFPmutants and analyzed by immunoblotting (Fig. 4A).
As is obvious from the figure, pUL77-mGFP was detected in the
virions of the mutants, and pUL93 was found in all virion prepa-
rations.Major andminor capsid proteins (MCPandmCP, respec-
tively) were used as positive controls for viral proteins associated
with virions, and the nuclear, nonstructural IE1 protein served as
a negative control, which was present in cell lysates, but not in
virus particles, underlining the purity of the virion preparations.
Next we assessed the amounts of pUL77-mGFP and pUL93 in
virus particles in comparison to A and B capsids using immuno-
blotting and determined the ratios of the pUL77-mGFP and
pUL93 signals to the MCP signals (Fig. 4B). Again, this experi-
ment also did not point to a preference of either pUL77-mGFP or
pUL93 for A capsids, yet virions contained larger amounts of both
pUL77-mGFP and pUL93 thanAor B capsids (Fig. 4B; factor 2 for
pUL77-mGFP and factor 2.7 for pUL93). As expected, large
amounts of pp150 were associated with virus particles only (Fig.
4B, lowest panel).
Having shown that pUL77-mGFP is present in virions, we ex-
pected also a fluorescence signal of particles in the cytoplasm,
where they undergo further tegumentation and secondary envel-
opment. In fixed and permeabilized cells, we did not detect a dis-
tinct cytoplasmic localization of pUL77-mGFP (c.f. Fig. 2) and
therefore investigated additionally living cells. As is shown in Fig.
4C, pUL77-mGFP was found in the cytoplasm of infected fibro-
blasts late in infection,mostly in a juxtanuclear region reminiscent
of the HCMV assembly compartment.
In summary, these results show that pUL77 and pUL93 are
structural proteins that remain associated with capsids and are
ultimately incorporated into mature extracellular virus particles.
Viral proteins interacting with pUL77-mGFP. We then ex-
amined which of the HCMV capsid proteins are interacting with
pUL77-mGFP and may thus mediate its binding to capsids. For
this, fibroblasts were infected with either HB5 or HB5-UL77-
mGFP-3, cell lysates were prepared, and pUL77-mGFPwas pulled
down using GFP-Trap beads. This approach utilizes fragments of
Camelidae GFP Abs (nanobodies), which combine the character-
istics of high-affinity binding and small size (10 kDa compared
to 150 kDa for conventional Abs). This enables the nanobodies to
gain access toGFP evenwhen hidden in small cavities (asmight be
the case for pUL77-mGFP when incorporated into viral capsid
structures). Viral protein levels in whole-cell lysates (Fig. 4D, left
panels, input) of parental andmutant virus-infected cells demon-
strated comparable infection efficiency. As expected, pUL77-
mGFP could be precipitated from lysates of cells infected with
HB5-UL77-mGFP-3 (Fig. 4D, right panels, bound). Several viral
proteins copurified with pUL77-mGFP, namely, pUL93 and the
capsid proteins MCP, mCP, mCP-BP, and SCP, as well as the
tegument protein pp150. No evidence of association of the puta-
tive 48-kDa pUL93 version was obtained as exclusively the full-
length 68-kDa protein was visible. The terminase subunits pUL56
and pUL89 were not detected in the fraction of proteins pulled
down with pUL77-mGFP, and also the pUL50 and pUL53 com-
ponents of the nuclear egress machinery (49, 50), as well as the
encapsidation protein pUL52 (21), were not observed. Few pro-
teins exhibited some unspecific attachment to the beads, as can be
seen by the weak signals obtained for theHB5 sample (i.e., pUL93,
mCP, and pUL89 [Fig. 4D, lane 3]). Here, the differences in signal
strength between the HB5 and HB5-UL77-mGFP-3 samples (Fig.
4D, right panels, bound) indicated that pUL93 and mCP do asso-
ciate with the pUL77-mGFP fusion protein, whereas the signals
for pUL89 were similar, reflecting background binding.
These results suggested a number of potential viral interaction
partners for pUL77. An alternative explanation would be that
ratherwhole capsids than individual proteinswere coprecipitated.
When examining the lysates of infected cells used for theGFP-trap
pulldown assays by EM, we could indeed find capsids as well as
structures resembling capsid fragments (data not shown).
Requirements for subnuclear localization and for interac-
tions of pUL77. To further dissect the observed pUL77 protein
interactions, we asked which viral proteins are necessary for these
interactions to occur and disrupted the ORFs encoding the major
capsid protein (MCP), pUL52, pUL93, or pp150 in the BACHB5-
UL77-mGFP-3. HCMV BACs with mutations in essential genes
are not infectious, and no complementing cells were available for
propagation of most of these mutants. To overcome these limita-
tions, we applied a transfection protocol that allows the study of
essential viral proteins directly in cells transfected with the respec-
tive HCMV deletion genomes (29). Using this method, which is
based on defective adenovirus particles as carriers and was there-
fore termed “adenofection,” we transfected HCMV-permissive
RPE-1 cells with the parental BACHB5orHB5-UL77-mGFP-3, as
well as with the deletion genomes derived from HB5-UL77-
mGFP-3. There was no difference in the localization of pUL77-
mGFP between cells transfected withHB5-UL77-mGFP-3 or with
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FIG 4 Detection of pUL77-mGFP and pUL93 in virus particles and identification of viral proteins associated with pUL77-mGFP. (A) Virus particles purified
from the supernatant of fibroblasts infected with the parental virusHB5 or theHB5-UL77-mGFPmutants (MOI of 1) were analyzed by immunoblotting (right).
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genomes lacking intact ORFs for pUL52 or pp150 (Fig. 5A). Over-
lap of the pUL77-mGFP and pUL89 signals—the latter being a
marker for the replication centers—confirmed that pUL77-
mGFP is mainly found in this compartment. When pUL93 or the
MCP was missing, pUL77-mGFP was no longer detectable, possi-
bly because it was dispersed throughout the cell and hence was
below the detection limit of the microscope settings applied.
These results indicate that pUL93 is crucial for the correct local-
ization of pUL77-mGFP within nuclei. The fact that MCP was
necessary as well indicates that it is either directly involved in
pUL77-mGFP nuclear targeting or that correct localization of the
fusion protein is dependent on the presence of assembled capsids.
Furthermore, viral genome encapsidation is not a prerequisite for
the proper subcellular distribution of pUL77-mGFP, because the
cleavage-packaging protein pUL52 proved to be dispensable for
its nuclear localization.
Another reason why pUL77-mGFP was not detectable by flu-
orescence microscopy anymore could be that it was degraded
when pUL93 orMCPweremissing. Immunoblot analysis demon-
strated, however, that the fusion protein was present in all RPE-1
cells adenofected with HB5-UL77-mGFP-3 or the derivatives of it
(Fig. 5B, top panel). For the genomes that do not express UL52,
pp150, or MCP, the absence of the respective proteins was con-
firmed (Fig. 5B). Interestingly, upon knockout of the ORF for
MCP, the SCP became undetectable in the cell lysate as well (Fig.
5B, SCP, lane 6). In cells transfected with the UL93-null genome,
the UL93-specific MAb detected an 42-kDa protein (Fig. 5B,
second panel, lane 5). The size of this protein is compatible with
translation commencing at the first start codon of the UL93 ORF
and terminating at the introduced stop codon (c.f. scheme at the
bottom of Fig. 5B), supporting our other data that point to the use
of the first ATG for pUL93 synthesis.
To investigate which interactions of pUL77-mGFP can still oc-
cur when one of the mentioned proteins is missing, the fusion
protein was precipitated from the respective cell lysates (Fig. 5C,
first panel). Examination of the cell lysates by EM confirmed that
in the absence ofMCP, capsid formation did not occur, whereas it
was not affected when one of the other proteins was missing (in-
dicated at the bottom of Fig. 5B) (data not shown). For detection
of interaction partners coprecipitating with pUL77-mGFP from
lysates of transfected RPE-1 cells, long exposure times were
needed. This led to high background signals, resulting from non-
specific attachment of proteins to the beads, as can be seen in the
lane for the HB5 control lysate (Fig. 5C, lane 1). Despite this tech-
nical limitation, we concluded the following: (i) in the absence of
pUL52—a protein that is not a capsid component and does not
interact with pUL77-mGFP (c.f. Fig. 3B and 4D)—association of
pUL77-mGFP with the viral proteins tested was not affected (Fig.
5C, lane 3), (ii) the samewas observed when the tegument protein
pp150 was missing (Fig. 5C, lane 4), and (iii) in lysates of cells
transfected with the UL93 BAC, the truncated 42-kDa UL93 pro-
tein was coprecipitated with pUL77-mGFP, and also capsid pro-
teins and pp150 did copurify. Apparently, the truncated UL93
protein can still mediate interaction to some extent, although this
is not sufficient for correct localization of pUL77-mGFP and the
generation of infectious progeny. Since capsids are made when
either the UL52, UL32 (encoding pp150), or UL93 ORF is dis-
rupted, we cannot make a conclusion about individual protein-
protein interactions as coprecipitation with pUL77-mGFP could
also reflect pulldown of whole capsids. However, when MCP was
missing and capsid assembly was prevented, we still observed in-
teraction with pUL93, mCP, mCP-BP, and pp150 (Fig. 5C, lane
6). This hints at the formation of higher-order protein complexes
of the structural viral proteins even in the absence of capsid for-
mation.
Functional consequences of UL77 or UL93 deletion. Having
shown that pUL77-mGFP and pUL93 are capsid constituents, we
next asked whether these proteins may play a role in HCMV ge-
nome encapsidation. To this end, either UL77 or UL93 was de-
leted from the HG genome, an AD169 strain-based EGFP-ex-
pressing HCMV BAC (31). We first tested if genome cleavage is
still carried out after disruption of UL77 or UL93. The mutated
genomes were used for adenofection of RPE-1 cells, and total
DNAwas analyzed 5 days posttransfection by pulsed-field gel elec-
trophoresis and Southern blotting with a probe specific for the
viral genome (Fig. 6A). For both HG-UL77 and HG-UL93,
similar amounts of newly replicated concatemeric viral DNAwere
obtained compared to the parental HG genome (Fig. 6A, signal
labeled “well”). Concatemeric DNA is of high molecular weight
and is believed to adopt branched and complex structures, and
thus is retained within the wells of the gel. Conversely, when ge-
nome cleavage takes place, unit-length genomes can be resolved in
pulsed-field gels and are detected at approximately 240 kbp (Fig.
6A). (The 400- to 700-kbp DNA species also seen in Fig. 6A pre-
sumably represents intermediate products of the cleavage pro-
cess.) As shown in Fig. 6A, after deletion of UL77 or UL93, unit-
length genomes were not detectable any longer, implying that
genome cleavage does not (or does not efficiently) occur in the
absence of these viral proteins.
Since viral genome packaging and cleavage occur concomi-
tantly, we also investigatedwhich capsid typeswere present in cells
adenofected with the UL77 or UL93mutant genomes (Fig. 6B and
C). In cells transfectedwith the parental HG genome and analyzed
by transmission EM, all three capsid types were identified (Fig. 6B,
first panel), whereas upon transfection of the mutated genomes,
only B capsids were found (Fig. 6B, second and third panels). The
percentages of the different capsid types were quantified (Fig. 6C),
corroborating the absence of A and C capsids in cells transfected
with HG-UL77 or HG-UL93. This is in line with our observa-
tion that viral genomes remain uncleaved when pUL77 or pUL93
is missing. The exclusive occurrence of B capsids, which are
thought to be dead end products arising from spontaneous angu-
larization of procapsids, together with the lack of A capsids that
originate from abortive DNA packaging attempts, suggested that
genome packaging is not even initiated in the absence of pUL77 or
pUL93. In summary, these data assign an essential role to both
pUL77 and pUL93 for HCMV genome encapsidation.
DISCUSSION
In this work, we analyzed the properties and functions of the es-
sential HCMV UL77 and UL93 proteins. Our results show that
both pUL77 and pUL93 are expressed with late kinetics and are
structural components incorporated into capsids as well as viri-
ons. The pUL77-mGFP fusion protein was detected on all three
capsid types (A, B, and C) in similar amounts. In the absence of
pUL77 or pUL93, viral genome encapsidation did not ensue, and
only empty B capsids were produced. pUL77-mGFP was found to
interact with pUL93, as well as with capsid proteins and also with
the betaherpesvirus-specific tegument protein pp150, and these
interactions even occurred when capsid assembly was prevented.
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However, the localization of pUL77-mGFP to nuclear replication
compartments required the presence of pUL93 as well as of the
major capsid protein (i.e., intact capsids), but was independent of
the tegument protein pp150 or the cleavage-packaging protein
pUL52, demonstrating that C capsid formation is not a prerequi-
site for correct subnuclear distribution of pUL77. Taken together,
our results indicate that pUL77 and pUL93 are important compo-
nents of the HCMV encapsidation network.
While in alphaherpesviruses, several mutants encoding fluo-
rescent capsid proteins have been generated successfully (23, 51–
54), similar HCMV mutants were not available. Our previous at-
tempts to label the CMV small capsid protein (SCP) with GFP did
not result in viable progeny, because it turned out that—in con-
trast to alphaherpesviruses—the SCP is essential in both mouse
CMV (MCMV) and HCMV (14). A major step forward was the
recent generation of an MCMV recombinant in which EGFP is
fused to SCP at a different position than before, although this
MCMV mutant has to incorporate the native SCP in addition to
the EGFP fusion into its capsids to be viable (55). For HCMV,
addition of the EGFP to pp150 (as well as tagging of the envelope
protein gMwithmCherry) provided a valuable tool to study virus
entry and intracellular particle movement (47, 56). pp150 was
recently defined as the innermost tegument protein of HCMV
(12), and although its addition to capsids commences in the nu-
cleus, the majority of pp150 is acquired in the cytoplasm. Thus,
the UL77-mGFP virus described here represents the first HCMV
mutant with a fluorescently labeled capsid. In this study, we uti-
lized the GFP tag mainly as a means to pull down interacting
proteins of pUL77; however, in future studies, this mutantmay be
a versatile tool to investigate capsid assembly, nuclear capsid traf-
ficking, or nuclear egress, for instance, by live cell imaging.
By examining the expression of pUL77-mGFP and pUL93 dur-
ing HCMV infection, we found that both proteins are of late ki-
netics. This is in accordance with a recent proteomics study of
HCMV-infected cells, indicating that pUL77 and pUL93 are late
proteins expressed simultaneously (57). In our immunoblotting
experiments, pUL93 was seen as a major band migrating with a
molecularmass of 68 kDa and as aminor formof 48 kDa. This was
unexpected, since a recent study reporting on ribosome profiling
with HCMV-infected cells did not find evidence for usage of the
first ATG of the UL93 ORF, which would yield a 68-kDa protein
(46). Instead, it was proposed that translation starts at internal
initiation codons, giving rise to smallerUL93 proteins or peptides.
For the following reasons, we believe that the full-length pUL93 is
the biologically relevant protein species: (i) the 68-kDaUL93 pro-
tein was expressed at high levels, whereas only small amounts of
the 48-kDa formwere found, (ii) predominantly the 68-kDaUL93
protein was detected in capsids and virions and was also the one
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interacting with pUL77-mGFP, and (iii) the interruption of the
UL93ORF yielded a nonfunctional, C-terminally truncated UL93
protein with a size that exactlymatched a product whose synthesis
starts at the first ATG.
Inspection of capsids isolated from the nuclei of infected cells
and of extracellular virions demonstrated that pUL77 and pUL93
are capsid constituents that stay associated with capsids and are
incorporated into virus particles. The latter finding is in line with
proteomic analyses of HCMV particles, in which peptides origi-
nating from pUL77 and pUL93 were detected (58, 59). Also, cap-
sid-association of pUL77 was previously seen after fractionation
of extracellular HCMV particles into envelope, tegument, and
capsid (28). The association of pUL77 and pUL93 with nuclear
capsids is described here for the first time. Further EM experi-
ments revealed that pUL77-mGFP is present on A, B, and DNA-
filled C capsids in comparable amounts, and quantitative immu-
noblotting showed equal amounts of pUL77 as well as of UL93 on
A and B capsids. This is different from the UL25 protein of alpha-
herpesviruses, whose abundance increases from B to A to C cap-
sids (24, 25, 60–64). In fact, the HSV-1 UL25/UL17 heterodimer
was initially considered to be attached exclusively to C capsids and
was thus termed the “C capsid-specific component” (CCSC) (25),
yet its subsequent detection in A and B capsids led to its renaming
as the “capsid vertex-specific component” (CVSC) (27). The en-
richment of CVSC on C capsids described by several groups gave
rise to the hypothesis that addition of CVSC concomitant with
viral DNA packaging creates a signature indicating that mature
capsids are ready for nuclear egress. At first glance, the finding that
pUL77-mGFP is apparently present in similar amounts on all
three capsid types—which needs to be corroborated by means of
other techniques such as cryo-electron microscopy (cryo-EM)—
argues against pUL77 providing the signal that triggers nuclear
egress. In this respect, one has to point out that the organizations
of the tegument of alpha- and betaherpesviruses differ (10, 11),
and moreover, HCMV encodes additional tegument proteins
which are specific for betaherpesviruses and may take over this
task. On the other hand, it might be rather the joint binding of
pUL77 and pUL93 to C capsids concomitant with conformational
changes that could lead to the exposure of domains providing the
signal for nuclear egress. Assessment of pUL93 association with
different capsid types by immunogold labeling is therefore one of
the immediate next tasks. For this, we are currently generating
additional antibodies that will recognize as well the native protein.
Furthermore, we consider constructing an HCMV mutant that
expresses a UL93 protein tagged in a similar way as done for
pUL77. Future cryo-EM experiments will disclose whether pUL77
is indeed located at the capsid vertices and will elucidate the pre-
cise localization of pUL77 and pUL93 onHCMVcapsids and their
positions relative to other capsid and tegument proteins.
We could copurify pUL77-mGFP and pUL93, which is remi-
niscent of the interaction of the alphaherpesvirus CVSC proteins
pUL25 and pUL17. In addition, capsid proteins and pp150 were
identified in the immunoprecipitatedmaterial, which was not un-
expected, because a recent high-resolution cryo-EM study of
HCMV capsids showed spatial proximity of MCP, SCP, triplex
proteins, and pp150 (13).However, based on our data, one cannot
conclude that pUL77-mGFP and pUL93 interact directly with
these proteins. Since the cell lysates also contained capsid frag-
ments and even whole capsids, pulldown of one of the proteins is
sufficient to coprecipitate the other components. We did not ob-
serve an interaction of pUL77 with the terminase proteins pUL89
or pUL56, although the latter was reported before (28). This dis-
crepancy may be due to different experimental conditions. Even
so, the terminase is supposed to detach from capsids after cleav-
age-packaging is completed, and thus its capsid association may
be hard to discover. Likewise, the nuclear egress complex (NEC)
components pUL50 and pUL53 neither coprecipitated with
pUL77-mGFP nor were detected in nuclear capsids in substantial
amounts. In contrast, for alphaherpesviruses, an association of the
HCMVpUL53 homologue pUL31with capsids was reported (65–
67). Interaction of herpesvirus capsids with the NEC is transient
and probably of low affinity, because the capsids have to dissociate
from the NEC to get released into the cytosol. This may hamper
the detection of NEC components onHCMV capsids. Upon over-
expression of isolated proteins, interactions among the CVSCs of
different herpesviruses and terminase or NEC components were
seen (68–71). To assess whether during infection pUL77 or pUL93
is required for NEC binding, a similar approach to that described
for HSV-1 by Leelawong et al. (66) could be applied, using mu-
tants lacking either UL50 or UL53. This would lead to inhibition
of nuclear egress, stabilizing the capsid association with the re-
maining component of theNECand thus facilitating the detection
of the interaction.
We also investigated whether the subcellular localization of
pUL77 or its interaction with pUL93 depends on the presence of
other proteins of the HCMV encapsidation network. Correct lo-
calization of pUL77-mGFP was not impaired in the absence of
pp150 (UL32) or pUL52. The latter finding is contrary to that of
the HSV-1 pUL32 orthologue, which influences HSV-1 pUL25
nuclear localization (72). This may be due to the recently de-
scribed ability of pUL32 to affect the disulfide bond profile of
pUL25 (73, 74); however, it is not known whether HCMV pUL52
exerts a similar function. In any case, the results presented here
indicate that pUL52 is neither a capsid constituent nor an inter-
action partner of pUL77. The dependence of pUL77-mGFP local-
ization on pUL93 orMCP is similar to data obtained with HSV-1,
for which pUL17 and also capsid proteins are necessary for nu-
clear targeting of pUL25 (72). Although pUL77-mGFP and
pUL93 could still interact when capsid formation was abrogat-
ed—for instance, upon disruption of the MCP ORF—proper nu-
clear localization of pUL77 seems to depend on additional factors.
Whether pUL77 and pUL93 interact directly, as reported for the
corresponding proteins of alpha- and gammaherpesviruses (23,
24, 75), remains to be tested by expressing the proteins indepen-
dent of viral infection. Interestingly, in the accompanying article
by P. Köppen-Rung and colleagues (84), direct interaction of
pUL77 and pUL93 was confirmed by using such an approach, and
the domain mediating the binding to UL93 was mapped to the N
terminus of pUL77.
Following disruption of either the UL77 or UL93 ORF, viral
concatemeric genomes remained uncleaved, and exclusively B
capsids were detected, demonstrating that both proteins are es-
sential for HCMV genome encapsidation. The phenotype of the
UL93 mutant is comparable to that of alphaherpesvirus UL17 de-
letion mutants (76, 77). Moreover, a recent study using a UL93
mutant in which the initiation codonwasmutated to a stop codon
also established a pivotal role for pUL93 in genome cleavage and
packaging (36). Thus, our data provide evidence thatUL93 indeed
represents a functional orthologue of HSV-1 UL17, albeit the two
proteins do not share sequence similarity.
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In contrast, the phenotypic consequences resulting from dele-
tion of UL77 are different from those of UL25-null mutants of
alphaherpesviruses. pUL25 exerts its function after the viral DNA
has been cut (78, 79) and rather is involved in retention of ge-
nomes within capsids. The conformational changes in capsid
structure that accompany genome packaging are believed to ex-
pose pUL25 binding sites, resulting in preferential attachment of
pUL25 to C capsids and their stabilization (25, 64, 80). In cells
infected with UL25 deletion mutants, DNA-filled C capsids were
detected (27, 63), whereas upon capsid purification, a larger
amount of A capsids, but no C capsids, was seen (24, 52). These
findings are not necessarily contradictory, since the isolation of
nuclear capsids by gradient purification can lead to the loss of
capsid-associated proteins and of the packaged DNA (12, 13, 24).
The increased number of alphaherpesvirus A capsids suggested
thatDNApackagingwas initiated, yet the genomeswere not stably
retainedwithin capsids in the absence of pUL25. In support of this
scenario, small amounts of terminal genomic fragments indicative
of low-level genome cleavage in the absence of pUL25 were ob-
served (27, 78). We searched for genomic termini in RPE-1 cells
transfected with the UL77-deleted genome. However, the portion
of free genomic ends is already low in HCMV-infected fibroblasts
(18, 36) and was near the detection limit of the Southern blot
analysis of viral DNA isolated from RPE-1 cells transfected with
the parental HCMV BAC (data not shown). Therefore, a frac-
tional amount of terminal fragments possibly produced in the
absence of pUL77 cannot be evaluated in this setting. Still, the lack
of C (and A) capsids in UL77-transfected cells distinguishes
pUL77 from its alphaherpesvirus orthologues, overall pointing to
a somehow different function in betaherpesviruses. Notably, even
the roles of the CVSC proteins of alphaherpesviruses seem to be
slightly divergent, as functional complementation of pUL17 or
pUL25 between PRV and HSV-1 (and vice versa) was not or was
only partially possible (81, 82).
Another unsettled issue—also in alpha- and gammaherpesvi-
ruses—is whether the CVSC is also present at the portal vertex. If
this was the case inHCMV, our finding that DNApackaging is not
even attempted in the absence of pUL77 or pUL93 hints at an
effect of the CVSC on the portal protein or the interaction of the
portal with the terminase complex. Such virus-specific protein-
protein interactions may constitute an Achilles heel of the virus
and could serve as targets for the development of novel antiviral
compounds (83). Further knowledge about the role and structure
of pUL77 and pUL93 may thus provide the basis for the design of
custom-tailored inhibitors.
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